Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
‘Opioids’ Is Missing From The US FDA’s Overdose Prevention Framework Title On Purpose
Sep 14 2022
•
By
Derrick Gingery
The Overdose Prevention Framework diverges from previous substance abuse plans, which were focused on opioids. • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from US FDA
More from Agency Leadership